J. Bradley Rivet is VP Marketing at ACURA PHARMACEUTICALS, INC (ACUR). They have made 1 open-market trade across 1 company since 2014, most recently 2014-05-19.
CIK 0001532054
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2K since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACUR | 2,000 | $1K |
Shares reported on the most recent Form 4, priced at the 2014-05-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACUR | BUY | 2014-05-19 | 2014-05-19 | $1.23 | $2K | -17.9% | -9.9% | -9.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.